Ms. Nicole Lemerond - 11 Jun 2024 Form 4 Insider Report for MEDICINOVA INC (MNOV)

Role
Director
Signature
/s/ Yuichi Iwaki, Attorney-in-Fact
Issuer symbol
MNOV
Transactions as of
11 Jun 2024
Net transactions value
$0
Form type
4
Filing time
12 Jun 2024, 19:40:36 UTC
Previous filing
26 Dec 2023
Next filing
14 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNOV Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 11 Jun 2024 Common Stock 20,000 $1.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in four equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025, subject to continued service with the Company.